TY - JOUR T1 - Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death JF - medRxiv DO - 10.1101/2022.01.17.22269434 SP - 2022.01.17.22269434 AU - Andreas Søborg AU - Joanne Reekie AU - Allan Rasmussen AU - Caspar Da Cunha-Bang AU - Finn Gustafsson AU - Kasper Rossing AU - Michael Perch AU - Paul S. Krohn AU - Søren S. Sørensen AU - Thomas K. Lund AU - Vibeke R. Sørensen AU - Christina Ekenberg AU - Louise Lundgren AU - Isabelle P. Lodding AU - Kasper S. Moestrup AU - Jens D. Lundgren AU - Neval E. Wareham Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/01/23/2022.01.17.22269434.abstract N2 - Monitoring specific underlying causes of death in solid organ transplant (SOT) recipients is important in order to identify emerging trends and health challenges.This retrospective cohort study includes all SOT recipients transplanted at Rigshospitalet between January 1st, 2010 and December 31st, 2019. The underlying cause of death was determined using the newly developed Classification of Death Causes after Transplantation (CLASS) method. Cox regression analyses assessed risk factors for all-cause and cause-specific mortality.Of the 1774 SOT recipients included, 299 patients died during a total of 7511 person-years of follow-up (PYFU) with cancer (N=57, 19%), graft rejection (N=55, 18%) and infections (N=52, 17%) being the most frequent causes of death.We observed a lower risk of all-cause death with increasing transplant year (HR 0.91, 95% CI 0.86-0.96 per 1-year increase), alongside death from graft rejection (HR 0.84 per year, 95% CI 0.74-0.95) and death from infections (HR 0.87 per year, 95% CI 0.77-0.98).Further, there was a trend towards lower cumulative incidence of death from cardiovascular disease, graft failure and cancer in more recent years, while death from other organ specific and non-organ specific causes did not decrease.All-cause mortality among SOT recipients has decreased over the past decade, mainly due to a decrease in graft rejection- and infection-related deaths. Conversely, causes from a broad range of diseases have remained unchanged, suggesting that cause of death among SOT recipients is increasingly diverse and warrants a multidisciplinary effort and attention in the future.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Danish National Research Foundation (grant number DNRF126, CHIP & PERSIMUNE ). Further, Rigshospitalets Forskningspuljer pre-graduate research grant (project account number: E-23998-01) was awarded to author AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableThe authors cannot disclose individual level data because of ethical and legal data protection restrictions and have included group level data in the paper and tables. The dataset from this study is held securely in coded form at Centre of Excellence for Health, Immunity and Infections (CHIP). While national data protection laws and ethical regulations as well as cooperation agreements prohibit CHIP from making the dataset publicly available, requests for access to anonymized or pooled data may be sent to the Data Access Committee of CHIP, email: persimune.rigshospitalet{at}regionh.dk. ER -